Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Studies from Federal University of Minas Gerais in the area of vaccines described
August 13th, 2008
Investigators publish new data in the report 'Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice.' According to a study from Belo Horizonte, Brazil, "Sm14 and paramyosin are two major Schistosoma mansoni vaccine candidate antigens. Recently, we have identified Sm14 and paramyosin epitopes that are recognized by T cells of resistant individuals living in endemic areas for schistosomiasis." "Herein, mice were immunized with these peptides separately or in association in order to evaluate their vaccine...
Source: Vaccine Weekly (2008-08-13)
|
